|
MFSD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.09434724907487E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65140001673336E-09 |
| Normal-vs-Stage2 |
1.63529999541723E-08 |
| Normal-vs-Stage3 |
1.63419999754666E-09 |
| Normal-vs-Stage4 |
4.46710002321993E-10 |
| Stage1-vs-Stage2 |
7.902400E-02 |
| Stage1-vs-Stage3 |
1.527640E-01 |
| Stage1-vs-Stage4 |
3.255700E-02 |
| Stage2-vs-Stage3 |
5.412800E-01 |
| Stage2-vs-Stage4 |
8.013600E-01 |
| Stage3-vs-Stage4 |
3.554800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27150512341245E-11 |
| Normal-vs-AfricanAmerican |
7.584600E-04 |
| Normal-vs-Asian |
8.03220000000771E-05 |
| Caucasian-vs-AfricanAmerican |
5.613400E-01 |
| Caucasian-vs-Asian |
1.914040E-01 |
| AfricanAmerican-vs-Asian |
7.407000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.97629698664537E-11 |
| Normal-vs-Female |
1.23740018231899E-10 |
| Male-vs-Female |
3.054800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.81099999943635E-08 |
| Normal-vs-Age(41-60Yrs) |
1.26569976721669E-10 |
| Normal-vs-Age(61-80Yrs) |
5.20239962220614E-10 |
| Normal-vs-Age(81-100Yrs) |
4.600700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.886200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.656300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.803000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.925200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.896600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.289800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.043350E-01 |
| Classical-VS-Follicular |
3.139700E-03 |
| Classical-VS-Other |
3.372800E-01 |
| Classical-VS-Normal |
5.96729998747492E-09 |
| Tall-VS-Follicular |
7.190000E-01 |
| Tall-VS-Other |
8.864800E-01 |
| Tall-VS-Normal |
1.10630000049738E-07 |
| Follicular-VS-Other |
9.638000E-01 |
| Follicular-VS-Normal |
8.03370037161244E-10 |
| Other-VS-Normal |
5.537900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.87989656963828E-11 |
| Normal-vs-N1 |
1.02290000003613E-06 |
| N0-vs-N1 |
4.777000E-01 |
|
|
